Ultrasonography in developmental dysplasia of the hip: what have we learned?
Jennifer Bracken, Michael Ditchfield
https://pubmed.ncbi.nlm.nih.gov/22940710/Actively Recruiting
Led by Maidstone & Tunbridge Wells NHS Trust · Updated on 2026-03-23
70
Participants Needed
1
Research Sites
26 weeks
Total Duration
Developmental Dysplasia of the Hip DDH is a common condition in infants that can lead to disability if not treated properly. This research aims to find out whether babies with stable but immature Graf type 2b and 2c hips need treatment with a Pavlik harness or if their hips can mature naturally without it. The study is a feasibility trial conducted to compare the outcomes of babies treated with the harness versus those who are closely monitored without initial treatment. Babies in the study will be randomly assigned to one of two groups. One group will receive the usual care involving a Pavlik harness worn 24 hours a day for up to 12 weeks, with ultrasound scans at 3, 8, and 12 weeks after treatment begins. The other group will be under watchful waiting, having ultrasound scans every 3 weeks at 3, 6, 9, and 12 weeks to monitor hip maturation. If hips in the monitoring group do not mature, babies will be switched to harness treatment. Both groups will have X-rays taken at 9 and 15 months to assess long-term hip development. Participants will undergo baseline assessments including ultrasound and physical exams, and parents will complete stress questionnaires at various points. The harness group will have regular checks to ensure proper fit and monitor skin and nerve health. Parents in both groups will have access to support and emergency contact. The study will last 15 months per participant, with data collected on hip development, parent stress, and treatment outcomes to help determine if harness treatment is necessary for stable, immature hips.
CONDITIONS
Pavlik Harness Treatment vs Monitoring for Treatment of Developmental Dysplasia of the Hip (DDH) in Babies Diagnosed With Graf Type 2 Hips
N
Nicole Hilburn, PhD
J
Joanne Dartnell, Consultant Orthopaedic Surgeon
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Maidstone & Tunbridge Wells NHS Trust
Lead Sponsor
Canterbury Christ Church University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants are randomly assigned to either receive Pavlik harness treatment or undergo active surveillance with regular ultrasound scans to monitor hip development.
Ultrasound scans at 3, 6, 9, and 12 weeks; harness group has harness checks at 1, 3, 6, and 9 weeks; parenting stress assessments at baseline and 3 weeks
Duration - Up to 15 months of age
Participants who do not achieve hip maturation by 12 weeks may receive further treatment with an abduction splint until their x-ray at 9 months of age. Additional x-rays are performed at 9 and 15 months of age to assess long-term hip development.
X-ray visits at 9 and 15 months of age
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Jennifer Bracken, Michael Ditchfield
https://pubmed.ncbi.nlm.nih.gov/22940710/Maidstone & Tunbridge Wells NHS Trust
Lead Sponsor
Canterbury Christ Church University
Collaborating Sponsor